Showing results (61-70 of 198) with videos related to

Sort By:
Pageof 20
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 17, 2009
Antipsychotic effects on auditory sensory gating in schizophrenia patientsEva María Sánchez-Morla, José Luis Santos, Ana Aparicio, et al.
Bipolar Disorders|June 10, 2014
A five-year follow-up study of neurocognitive functioning in bipolar disorderJosé Luis Santos, Ana Aparicio, Alexandra Bagney, et al.
Journal of the National Cancer Institute|March 20, 2003
Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastasesHisanori Uehara, Sun Jin Kim, Takashi Karashima, et al.
Schizophrenia Research|February 16, 2010
P50 gating in deficit and nondeficit schizophreniaJosé Luis Santos, Eva María Sánchez-Morla, Ana Aparicio, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 6, 2004
Combined laser capture microdissection and serial analysis of gene expression from human tissue samplesJeong Hee Cho-Vega, Patricia Troncoso, Kim-Anh Do, et al.
The Journal of Urology|July 29, 2020
The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active SurveillanceJustin R Gregg, Devaki Shilpa Surasi, Alexandria Childs, et al.
Clinical Genitourinary Cancer|February 15, 2008
Phase II study of azacitidine to restore responsiveness of prostate cancer to hormonal therapyGuru Sonpavde, Ana Aparicio, Israel Guttierez, et al.
Revista Espanola De Enfermedades Digestivas|February 24, 2022
Mesalazine induced interstitial pneumonitis in the COVID eraAna Aparicio Serrano, Elma Gallego Jiménez, Javier Castro Rodríguez, et al.
The Oncologist|November 18, 2024
Leptin levels are associated with coronary artery calcification in patients with advanced prostate cancerEfstratios Koutroumpakis, Neha Venkatesh, Ana Aparicio, et al.
Current Medical Research and Opinion|July 27, 2007
The VIOXX in Prostate Cancer Prevention study: cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groupsJanet van Adelsberg, Peter Gann, Amy T Ko, et al.
Pageof 20